EORTC-1944-QLG-STBSG

Back to Clinical Trials Database

Long-term survivorship challenges of advanced/metastatic GIST patients responding to Imatinib treatment: An observational study

Study documentation

Trial Status	Recruiting
Dates	Date of activation: 24-Mar-2021
Data management at EORTC	None
Design	QoL Non Mod Dev. Not randomized / N.A.
Treatment	None
Study Staff	Emma Lidington (Study Coordinator) , Radboud University Medical Center Nijmegen, Nijmegen Melanie Beauvois (Clinical Operations Manager) , EORTC Headquarters, Brussels Corneel Coens (Statistician) , EORTC Headquarters, Brussels Ingrid Desar (Study Co-Coordinator) , Radboud University Medical Center Nijmegen, Nijmegen Francesca Martinelli (QoL Specialist) , EORTC Headquarters, Brussels Madeline Pe (QoL Specialist) , EORTC Headquarters, Brussels Winette van der Graaf (Study Co-Coordinator) , The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam
Type of cancer	Soft Tissue and Bone Sarcoma
Participating groups	EORTC Quality of Life Group EORTC Soft Tissue and Bone Sarcoma Group
Protocol summary	http://clinicaltrials.gov/ct/show/
NCT number
Financial Support	EORTC Group